| If
you cannot view the eLetter, or the links do not work, you can read
it on the Web at
http://www.scleroderma.org/e-letters/eLetter_131.htm.
If someone has forwarded this eLetter to you, and you
wish to subscribe to this FREE weekly publication, go to http://www.scleroderma.org/e_letter_signup.shtm.
|
|
Email
Us
Free
Info Packet
Calendar
Magazine
Chat
Medical
Archive
Support
SF
SF
Store
SF
Home Page
 |
| Philip
Nauert, D.D.S. |
Scleroderma
and Dental Health
By Philip Nauert, D.D.S. (originally published in "Scleroderma
Foundation Newsline," Summer/Fall 1999)
The ability to effectively chew nutritious and appealing food is
vital to a healthy body. Any process that compromises this simple
function can result in poor nutrition and a reduced ability to resist
opportunistic diseases.
Scleroderma can compromise oral and dental
health in a number of ways. In this article, we will look at some
of the more common dental problems complicated by scleroderma and
I will suggest some ways you can prevent or manage them.
|
|
| |
 |
| Members
of the Austin Support Group greeted Jim Filanc. |
After
a weeklong journey that started Monday in California, the
Racing For Life team finds itself visiting with the Scleroderma
Foundation Support Groups in Houston, Texas and Baton Rouge,
Louisiana today. |
 |
|
The
Workshop focuses on research related to the pathogenesis of
scleroderma and brings together scientists and clinical investigators
to promote scientific exchange in relevant cell and molecular
biology disciplines, to review clinical trials and methodology,
and to create a strong bridge from bench to bedside.
This
Workshop is co-chaired by the Boston University School of
Medicine and the Scleroderma Research Unit at the Royal Free
Hospital in London, UK. Held biennially, the last meeting
was held in Cambridge, UK in 2004.
|
|
|
On
February 27, Santarus, Inc. announced that the FDA approved
its new drug application for Zegerid (omeprazole/sodium bicarbonate)
capsules, an immediate-release proton pump inhibitor (PPI).
Zegerid capsules were approved for all of the indications
the company was seeking. |
|
|
Actelion
and FDA notified healthcare professionals of changes to the
Tracleer (bosentan) prescribing information based on cases
of hepatotoxity reported. |
|
Watch
Kenny Wallace Race
 |
Kenny
Wallace |
This week Kenny Wallace and the ppc Racing/Autozone car take
part in the Telcel-Motorola 200 presented by Banamex. The
race will be held at the Autodromo Hermanos Rodriguez on March
5.
It airs on the Fox television and MRN radio network. Please
check your local listing for broadcast times and watch for
the Scleroderma Foundation logo as it goes fast and turns
left! |
|
|
Next
Chat: Wed., Feb. 8, 9:30 p.m. Eastern Time. |
|
|
In
addition to our nationwide network of Chapters
and Support
Groups, we offer you electronic ways to connect with other
people. |
|
|
March 11 (Sat.): Tri-State
Chapter Scleroderma Educational Forum. (Liverpool, N.Y.)
March 11 (Sat.): North
Mississippi Support Group Welcomes Dr. Arnold Postlethwaite.
(Horn Lake, Miss.)
March 11 (Sat.): Oregon
Chapter's 5th Annual Scleroderma Seminar. (Portland, Oregon) |
|
|
|
